Stock Updates

Is this Large Market Cap Stock target price reasonable for Valeant Pharmaceuticals International, Inc. (NYSE:VRX)?

The company in question is, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) currently with a stock price of 29.47 (2.47% today). The market cap for Valeant Pharmaceuticals International, Inc. is 10165.38, and is in the sector Healthcare, and Drug Delivery industry. The target price for Valeant Pharmaceuticals International, Inc. is 44.39. Currently Valeant Pharmaceuticals International, Inc. is trading with a P/E of *TBA, and a forward P/E of 3.82. Average volume for Valeant Pharmaceuticals International, Inc. is 29463.09 and so far today it is 13066800.

Performance in the last year for Valeant Pharmaceuticals International, Inc. has been -87.16%. For EPS growth, Valeant Pharmaceuticals International, Inc. has seen a growth of -133.00%, and is looking to grow in the next year to 17.90%. More long term stats show that EPS growth has been 4.40% over the last five years and could be 11.07% for the next five years. Valeant Pharmaceuticals International, Inc. has seen sales growth quarter over quarter at -50.60%, with EPS growth quarter over quarter at -780.40%. The 20-day simple moving average is 19.16%, with the 200-day simple moving average coming to -43.34%.

Since the IPO date for Valeant Pharmaceuticals International, Inc. on the 3/30/1994, Valeant Pharmaceuticals International, Inc. has seen performance year to date to be -71.01%. With Valeant Pharmaceuticals International, Inc. trading at 29.47, the dividend yield is *TBA, and the EPS is -2.86.

So could Valeant Pharmaceuticals International, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 0.99 and the P/B is at 1.92. The P/cash is 11.93, with P/free cash flow at 7.8.

Valeant Pharmaceuticals International, Inc. ability to deal with debt shows that the current ratio is 1.4, and the quick ratio is 1.1. This is with long term debt/equity at 5.81, and total debt/equity at 5.87.

In terms of margins, Valeant Pharmaceuticals International, Inc. has a gross margin of 74.70%, an operating margin of 7.70% and a profit margin of -9.60%.Payout ratio for Valeant Pharmaceuticals International, Inc. is *TBA. Return on assets come to -2.00% with return on investment coming to 3.70%.

Insider ownership for Valeant Pharmaceuticals International, Inc., is at 2.30% and institutional ownership comes to 66.80%. Outstanding shares are at 344.94. While shares float is 332.48. The float short is currently 9.94%, and short ratio is 1.12.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment